Jiangsu Bioperfectus Technologies Co., Ltd.

(SSE:688399)

BioPerfectus, a public listed company on Shanghai Stock Exchange (SSE:688399), has been one of the leading molecular diagnostic solution providers specialized in infectious diseases ever since 2010. With headquarters located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi’an, Taizhou, Hainan, and Yinchuan. Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream of creating a healthier future for our next generations.

62,000+㎡

An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios

800+

Over 800 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic

5,000,000+

Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases

global presence

90 Countries within a year

Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.

20000 Installation base

Bioperfectus Nucleic Acid Extraction Solutions
were launched in over 20,000 laboratories
globally with a well-trained and quick-response
customer service team.

Product Center

News Center

08-182022

Bioperfectus is officially recognized as the valued membership of IFCC

08-182022

SHANGHAI, CHINA, August 18, 2022Jiangsu BioPerfectus Technologies Co., Ltd. (hereinafter referred to as BioPerfectus) is pleased to announce that we are now officially recognized as the valued membership of theInternational Federation of Clinical Chemistry and Laboratory Medicine(IFCC). By becoming a Corporate Member of IFCC, Bioperfectus will continue to improve our scientific progress and our products' application in the in-vitro diagnostics around the globe under the guidance and standar...

08-162022

Your Problem, Our Solution

08-162022

View the replay of the webinar; please send an email to support@bioperfectus.com. At Bioperfectus, the excellent experience of our customers is our goal and the key to our job. Last Wednesday, we completed online technical training for our distribution local support in the Asia Pacific region. The webinar covers insightful training on Bioperfectus Nucleic Acid Extraction System, Nucleic Acid Extraction Kit, Real-Time PCR System, and product demonstration on the newly launched SAW-96 Nucle...

08-112022

MHRA Registration Approval for BioPerfectus Monkeypox Virus Real Time PCR Kit

08-112022

SHANGHAI, CHINA, August 11, 2022Jiangsu BioPerfectus Technologies Co., Ltd. (hereinafter referred to as BioPerfectus) is pleased to announce that Monkeypox Virus Real Time PCR Kit has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and is now officially available for Great Britain and Northern Ireland market. There were 2,859 confirmed cases and highly probable cases of monkeypox as of Aug. 4. in the UK. Earlier last month, the monkeypox outbreak set its h...

Learn More

Service Network

Support is only one step away

A good after-sales service is essential for efficiency of workload in PCR laboratory. Bioperfectus delivers most perfect service via our authorized distributors and global service center. With well-experienced service staff, sufficient spare-part inventory and fast global logistics, Bioperfectus aims to provide with the satisfactory solutions to our end users.We offer 24/7 after-sales service, prompt response and periodical training programs.

CONTACT US NOW

Tel: +86 021-5484 7326 Email: info@bioperfectus.com